Target	Disease	Drug_index	Drug
TNF	Arthritis	1	adalimumab [TNF-alpha inhibitor]
TNF	Ankylosing Spondylitis	2	adalimumab [TNF-alpha inhibitor], certolizumab pegol [TNF-alpha inhibitor], etanercept [TNF-alpha inhibitor], golimumab [TNF-alpha inhibitor], infliximab [TNF-alpha inhibitor]
TNF	Psoriatic Arthritis	2	adalimumab [TNF-alpha inhibitor], certolizumab pegol [TNF-alpha inhibitor], etanercept [TNF-alpha inhibitor], golimumab [TNF-alpha inhibitor], infliximab [TNF-alpha inhibitor]
TNF	Rheumatoid Arthritis	2	adalimumab [TNF-alpha inhibitor], certolizumab pegol [TNF-alpha inhibitor], etanercept [TNF-alpha inhibitor], golimumab [TNF-alpha inhibitor], infliximab [TNF-alpha inhibitor]
TNF	Psoriasis	3	adalimumab [TNF-alpha inhibitor], etanercept [TNF-alpha inhibitor], infliximab [TNF-alpha inhibitor]
TNF	Ulcerative Colitis	4	adalimumab [TNF-alpha inhibitor], golimumab [TNF-alpha inhibitor], infliximab [TNF-alpha inhibitor]
PIK3CA	Breast Carcinoma	5	alpelisib [PI3-kinase p110-alpha subunit inhibitor]
RXRA	Cutaneous T-Cell Lymphoma	6	bexarotene [Retinoid X receptor agonist]
RXRA	T-Cell Non-Hodgkin Lymphoma	6	bexarotene [Retinoid X receptor agonist]
MAP2K1	Melanoma	7	binimetinib [Dual specificity mitogen-activated protein kinase kinase 1 inhibitor]
MAP2K1	Metastatic Melanoma	8	binimetinib [Dual specificity mitogen-activated protein kinase kinase 1 inhibitor], cobimetinib fumarate [Dual specificity mitogen-activated protein kinase kinase 1 inhibitor], trametinib dimethyl sulfoxide [Dual specificity mitogen-activated protein kinase kinase 1 inhibitor]
MAP2K1	Cutaneous Melanoma	9	binimetinib [Dual specificity mitogen-activated protein kinase kinase 1 inhibitor], trametinib dimethyl sulfoxide [Dual specificity mitogen-activated protein kinase kinase 1 inhibitor]
TNF	Inflammation	10	certolizumab pegol [TNF-alpha inhibitor]
TNF	Crohn's Disease	11	certolizumab pegol [TNF-alpha inhibitor], infliximab [TNF-alpha inhibitor]
PIK3CA	Follicular Lymphoma	12	copanlisib hydrochloride [PI3-kinase p110-alpha subunit inhibitor]
TNF	Juvenile Idiopathic Arthritis	13	etanercept [TNF-alpha inhibitor]
TNF	Psoriasis Vulgaris	13	etanercept [TNF-alpha inhibitor]
TNF	Spondylitis	14	etanercept [TNF-alpha inhibitor], golimumab [TNF-alpha inhibitor]
MAP2K1	Neurofibromatosis	15	selumetinib sulfate [Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor]
MAP2K1	Neurofibromatosis Type 1	15	selumetinib sulfate [Dual specificity mitogen-activated protein kinase kinase; MEK1/2 inhibitor]